Search Results - Keith Johnson
- Showing 1 - 14 results of 14
-
1
-
2
-
3
Organic iron (III) complexing ligands during an iron enrichment experiment in the western subarctic North Pacific by Yoshiko Kondo, Shigenobu Takeda, Jun Nishioka, Hajime Obata, Ken Furuya, William Keith Johnson, C. S. Wong
Published in Geophysical Research Letters (2008-06-01)Get full text
Article -
4
-
5
-
6
High-Resolution, Non-Invasive Imaging of Upper Vocal Tract Articulators Compatible with Human Brain Recordings. by Kristofer E Bouchard, David F Conant, Gopala K Anumanchipalli, Benjamin Dichter, Kris S Chaisanguanthum, Keith Johnson, Edward F Chang
Published in PLoS ONE (2016-01-01)Get full text
Article -
7
Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene by Fernando Morales, Patricia Cuenca, Gerardo del Valle, Melissa Vásquez, Roberto Brian, Mauricio Sittenfeld, Keith Johnson, Xi Lin, Tetsuo Ashizawa
Published in Revista de Biología Tropical (2008-03-01)Get full text
Article -
8
Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy by Deepti Putcha, Michael Brickhouse, Alexandra Touroutoglou, Jessica A. Collins, Megan Quimby, Bonnie Wong, Mark Eldaief, Aaron Schultz, Georges El Fakhri, Keith Johnson, Bradford C. Dickerson, Scott M. McGinnis
Published in NeuroImage: Clinical (2019-01-01)Get full text
Article -
9
Tau propagation in the brain olfactory circuits is associated with smell perception changes in aging by Ibai Diez, Laura Ortiz-Terán, Thomas S. C. Ng, Mark W. Albers, Gad Marshall, William Orwig, Chan-mi Kim, Elisenda Bueichekú, Victor Montal, Jonas Olofsson, Patrizia Vannini, Georges El Fahkri, Reisa Sperling, Keith Johnson, Heidi I. L. Jacobs, Jorge Sepulcre
Published in Nature Communications (2024-06-01)Get full text
Article -
10
Racial and ethnic differences in plasma p‐tau217 ratio biomarker eligibility rates in a preclinical AD trial with lecanemab by Doris P. Molina‐Henry, Rema Raman, Andy Liu, Oliver Langford, Joel B. Braunstein, Philip B. Verghese, Venky Venkatesh, Shobha Dhadda, Michael Irrizary, Joshua D. Grill, Keith Johnson, Robert A. Rissman, Paul Aisen, Reisa A. Sperling, AHEAD 3‐45 Study Team
Published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2025-07-01)Get full text
Article -
11
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease by Catarina Tristão-Pereira, Stephanie Langella, Justin S. Sanchez, Vincent Malotaux, Bing He, Jorge Alcina, Jairo E. Martinez, Zoe Rubinstein, Ana Baena, Clara Vila-Castelar, Averi Giudicessi, Liliana Ramirez Gomez, Claudia Ramos, Daniel Vasquez, David Aguillon, Heidi I. L. Jacobs, Reisa A. Sperling, Keith Johnson, Jennifer R. Gatchel, Yakeel T. Quiroz
Published in Alzheimer’s Research & Therapy (2025-03-01)Get full text
Article -
12
Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis by Tyler E Miller, Tyler Brown, Yonatan Grad, Satchit Balsari, Keith Johnson, Jochen Lennerz, Julia Thierauf, James S Miller, Pablo Martinez de Salazar Munoz, Abhishek Bhatia, Bridget Bunda, Ellen K Williams, David Bor, Amir Mohareb, Wenxin Yang, Julian Villalba, Vivek Naranbai, Wilfredo Garcia Beltran, Doug Kress, Kristen Stelljes, Dan Larremore, A John Iafrate, Caroline Buckee
Published in BMJ Open (2023-03-01)Get full text
Article -
13
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease by Stephanie A. Schultz, Jeremy F. Strain, Adedamola Adedokun, Qing Wang, Oliver Preische, Jens Kuhle, Shaney Flores, Sarah Keefe, Aylin Dincer, Beau M. Ances, Sarah B. Berman, Adam M. Brickman, David M. Cash, Jasmeer Chhatwal, Carlos Cruchaga, Michael Ewers, Nick N. Fox, Bernardino Ghetti, Alison Goate, Neill R. Graff-Radford, Jason J. Hassenstab, Russ Hornbeck, Clifford Jack, Jr, Keith Johnson, Nelly Joseph-Mathurin, Celeste M. Karch, Robert A. Koeppe, Athene K.W. Lee, Johannes Levin, Colin Masters, Eric McDade, Richard J. Perrin, Christopher C. Rowe, Stephen Salloway, Andrew J. Saykin, Reisa Sperling, Yi Su, Victor L. Villemagne, Jonathan Vöglein, Michael Weiner, Chengjie Xiong, Anne M. Fagan, John C. Morris, Randall J. Bateman, Tammie L.S. Benzinger, Mathias Jucker, Brian A. Gordon
Published in Neurobiology of Disease (2020-08-01)Get full text
Article -
14
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET by Kwangsik Nho, Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael Deardorff, Kelley Faber, Martin R. Farlow, Tatiana Foroud, Sujuan Gao, Thea Rosewood, Jun Pyo Kim, Kelly Nudelman, Meichen Yu, Paul Aisen, Reisa Sperling, Basavaraj Hooli, Sergey Shcherbinin, Diana Svaldi, Clifford R. Jack, William J. Jagust, Susan Landau, Aparna Vasanthakumar, Jeffrey F. Waring, Vincent Doré, Simon M. Laws, Colin L. Masters, Tenielle Porter, Christopher C. Rowe, Victor L. Villemagne, Logan Dumitrescu, Timothy J. Hohman, Julia B. Libby, Elizabeth Mormino, Rachel F. Buckley, Keith Johnson, Hyun-Sik Yang, Ronald C. Petersen, Vijay K. Ramanan, Nilüfer Ertekin-Taner, Prashanthi Vemuri, Ann D. Cohen, Kang-Hsien Fan, M. Ilyas Kamboh, Oscar L. Lopez, David A. Bennett, Muhammad Ali, Tammie Benzinger, Carlos Cruchaga, Diana Hobbs, Philip L. De Jager, Masashi Fujita, Vaishnavi Jadhav, Bruce T. Lamb, Andy P. Tsai, Isabel Castanho, Jonathan Mill, Michael W. Weiner, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Department of Defense Alzheimer’s Disease Neuroimaging Initiative (DoD-ADNI), the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN), the Australian Imaging, Biomarker & Lifestyle Study (AIBL), Andrew J. Saykin
Published in Nature Communications (2024-09-01)Get full text
Article
